Opinion|Videos|September 16, 2024

Challenges in Managing Co-Morbid CRM Conditions

Key Takeaways

  • Polypharmacy and drug-drug interactions complicate the management of co-morbid CRM conditions, necessitating careful medication review and adjustment.
  • Overlapping symptoms of CRM conditions require a multidisciplinary approach for accurate diagnosis and effective management.
SHOW MORE

A panel of medical experts examines the challenges in managing co-morbid cardiometabolic conditions, emphasizing the most prevalent complications associated with this disease state.

Video content above is prompted by the following:

  • What are the major clinical challenges in managing patients with co-morbid CRM conditions?

This activity is supported by Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Company who provided financial support for this program.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo